Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Ultralife (ULBI) EBT (2016 - 2025)

Ultralife has reported EBT over the past 16 years, most recently at -$7.7 million for Q4 2025.

  • Quarterly results put EBT at -$7.7 million for Q4 2025, down 17.13% from a year ago — trailing twelve months through Dec 2025 was -$5.9 million (down 566.43% YoY), and the annual figure for FY2025 was -$5.9 million, down 566.43%.
  • EBT for Q4 2025 was -$7.7 million at Ultralife, down from -$1.8 million in the prior quarter.
  • Over the last five years, EBT for ULBI hit a ceiling of $4.7 million in Q2 2023 and a floor of -$7.7 million in Q4 2025.
  • Median EBT over the past 5 years was $678000.0 (2022), compared with a mean of $167105.3.
  • Peak annual rise in EBT hit 870.73% in 2024, while the deepest fall reached 607.67% in 2024.
  • Ultralife's EBT stood at -$635000.0 in 2021, then skyrocketed by 47.72% to -$332000.0 in 2022, then skyrocketed by 488.55% to $1.3 million in 2023, then tumbled by 607.67% to -$6.5 million in 2024, then dropped by 17.13% to -$7.7 million in 2025.
  • The last three reported values for EBT were -$7.7 million (Q4 2025), -$1.8 million (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.